Skip to main content
Main navigation
HIPRA 介紹
HIPRA 介紹
探索 HIPRA
歷史記錄
永續性 & CSR
HIPRA 遍佈世界各地
動物健康
動物健康
我們的產品
疫苗產品
診斷試劑
動物用藥
我們的服務
關於智能疫苗接種
HIPRASTATS
海博萊診斷服務
海博萊學院
線上計算機
知識
新闻
解決方案
豚
家禽
牛
羊及び山羊
ウサギ
魚
犬
人類健康
人類健康
治療領域
COVID-19
消化系統健康 (GoodGut)
R&D 專案
新聞
新聞稿
职业
聯絡我們
Select your language
English
Español
Català
Português
Français
Italiano
Deutsch
Nederlands
Dansk
Polski
Türkçe
Ελληνικά
Русский
中文
한국어
Tiếng Việt
ไทย
Bahasa Indonesia
到台灣人
Go
國家
Global
Afghanistan
Albania
Algeria
Angola
Argentina
Armenia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Benin
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
Bulgaria
Burkina Faso
Burundi
Cambodya
Cameroon
Canada
Chile
China
Colombia
Congo (Brazzaville)
Congo (Kinshasa)
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Dominican Republic
Ecuador
Egypt
El Salvador
Eritrea
Estonia
Finland
France
Georgia
Germany
Ghana
Greece
Guatemala
Guinea
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Ireland
Israel
Italy
Ivory Coast
Japan
Jordan
Kenya
Kuwait
Latvia
Lebanon
Libya
Liechtenstein
Lithuania
Luxembourg
Macedonia
Madagascar
Malaysia
Mali
Malta
Mauritania
Mauritius
Mexico
Morocco
Mozambique
Myanmar
Nepal
Netherlands
New Zealand
Nicaragua
Nigeria
Norway
Oman
Pakistan
Panama
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Rwanda
Saudi Arabia
Senegal
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States of America
Uruguay
Uzbekistan
Venezuela
Vietnam
Yemen
Zimbabwe
Submit
Select your language
English
Spanish
Català
Português
Français
Italiano
Deutsch
Nederlands
Dansk
Polski
Türkçe
Ελληνικά
Русский
中文
한국어
Tiếng Việt
ไทย
Bahasa Indonesia
到台灣人
Go
國家
Global
Afghanistan
Albania
Algeria
Angola
Argentina
Armenia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Benin
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
Bulgaria
Burkina Faso
Burundi
Cambodya
Cameroon
Canada
Chile
China
Colombia
Congo (Brazzaville)
Congo (Kinshasa)
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Dominican Republic
Ecuador
Egypt
El Salvador
Eritrea
Estonia
Finland
France
Georgia
Germany
Ghana
Greece
Guatemala
Guinea
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Ireland
Israel
Italy
Ivory Coast
Japan
Jordan
Kenya
Kuwait
Latvia
Lebanon
Libya
Liechtenstein
Lithuania
Luxembourg
Macedonia
Madagascar
Malaysia
Mali
Malta
Mauritania
Mauritius
Mexico
Morocco
Mozambique
Myanmar
Nepal
Netherlands
New Zealand
Nicaragua
Nigeria
Norway
Oman
Pakistan
Panama
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Rwanda
Saudi Arabia
Senegal
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States of America
Uruguay
Uzbekistan
Venezuela
Vietnam
Yemen
Zimbabwe
Submit
搜尋
搜尋
豬隻智慧型疫苗接種
豬隻 HIPRA 智慧型疫苗接種由我們的創新型 MHYOSPHERE® 豬環狀病毒 (PCV) ID 和 UNISTRAIN® 豬生殖與呼吸症候群 (PRRS) 疫苗,無針皮內裝置 Hipradermic®,以及專業獸醫應用程式 HIPRAlink® Vaccination帶頭。
可用的疫苗:
MHYOSPHERE® PCV ID
UNISTRAIN® PRRS
可用的設備:
Hipradermic®
Hipradermic® 是先進的無針注射裝置,可無線連接豬皮內疫苗接種。
More info
HIPRAlink® Vaccination
由 HIPRA 開發的專業獸醫應用程式,可在動物保健疫苗接種過程中提供可追溯性和相關資訊。
了解
相關出版物
Clostridioides Difficile: Pathology, risk, factors and diagnos
Comparative study of the humoral response and safety effects of two commercial reproductive vaccines under field conditions in breeding sows.
RHINISENG®: Efficacy of the basic vaccination scheme (vaccination and revaccination) and the booster vaccination
Efficacy of Suiseng® Diff/A vaccine and its associated use with Suiseng® Coli/C against C.difficile and C.perfringens type A
Efficacy of Suiseng® Coli/C vaccine and its association with Suiseng® Diff/A against Enterotoxigenic Escherichia coli
Effects of a new vaccine against Clostridioides difficile and Clostridium perfringens Type A
Assessment of the efficacy of ERYSENG® PARVO/LEPTO in Thailand
Assessment of the safety of ERYSENG® PARVO compared to a trivalent vaccine
Assessment of the humoral immune response against swine erysipelas
Use of qPCR to evaluate the presence of type B Clostridium novyi in sudden death sows and healthy sows
Reduction of the mortality rate using a Clostridium novyi vaccine
Prevalence of the pathogenicity factors of the Enterotoxigenic Escherichia coli and Clostridium perfringens type C
Previous
Next
最新消息
探索我們的最新消息
查看更多
Last news
HIPRA took part in the 54th Annual Conference of the American Association of Swine Veterinarians
VEPURED® and RHINISENG®: The first swine vaccines of HIPRA JAPAN
HIPRA participates as Gold sponsor in the XX International Congress Porkaméricas 2022
HIPRA KOREA presents its “Premium Sow Vaccine Program”
Future professionals from the pig sector visit HIPRA facilities
HIPRA at the IPVS 2022
MHYOSPHERE® PCV ID arrives in Asia
Switch off the non-rational use of antibiotics
Previous
Next